4.6 Article

(+)-Sesamin, a sesame lignan, is a potent inhibitor of gut bacterial tryptophan indole-lyase that is a key enzyme in chronic kidney disease pathogenesis

期刊

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2021.12.088

关键词

Chronic kidney disease; Tryptophan indole-lyase; Sesamum indicum L.; Sesamin; Sesamol; Enzyme inhibition

资金

  1. Ministry of Education, Culture, Sports, Science, and Technology of Japan [18H02822, 20K20604, 21H02932]
  2. Japan Agency for Medical Research and Development (AMED) [20ek0210133h0001, 20ak0101127h0001, J21000294]
  3. Grants-in-Aid for Scientific Research [21H02932, 18H02822, 20K20604] Funding Source: KAKEN

向作者/读者索取更多资源

The study found that sesamin and related lignans derived from sesame seeds can inhibit the activity of intestinal bacteria TILs, potentially serving as a mechanism-based strategy to prevent CKD progression. These phytochemicals competitively bind to EcTIL and may bind near the active site of the enzyme.
The progression of chronic kidney disease (CKD) increases the risks of cardiovascular morbidity and end-stage kidney disease. Indoxyl sulfate (IS), which is derived from dietary L-tryptophan by the action of bacterial (L)-tryptophan indole-lyase (TIL) in the gut, serves as a uremic toxin that exacerbates CKD-related kidney disorder. A mouse model previously showed that inhibition of TIL by 2-aza-L-tyrosine effectively reduced the plasma IS level, causing the recovery of renal damage. In this study, we found that (+)-sesamin and related lignans, which occur abundantly in sesame seeds, inhibit intestinal bacteria TILs. Kinetic studies revealed that (+)-sesamin and sesamol competitively inhibited Escherichia coli TIL (EcTIL) with K-i values of 7 mu M and 14 mu M, respectively. These K-i values were smaller than that of 2-aza-L-tyrosine (143 mu M). Molecular docking simulation of (+)-sesamin- (or sesamol-)binding to EcTIL predicted that these inhibitors potentially bind near the active site of EcTIL, where the cofactor pyridoxal 5'-phosphate is bound, consistent with the kinetic results. (+)-Sesamin is a phytochemical with a long history of consumption and is generally regarded as safe. Hence, dietary supplementation of (+)-sesamin encapsulated in enteric capsules could be a promising mechanism-based strategy to prevent CKD progression. Moreover, the present findings would provide a new structural basis for designing more potent TIL inhibitors for the development of mechanism-based therapeutic drugs to treat CKD. (C) 2021 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据